posted
it broke into the teens on less news and events not long ago and the numbers have not changed,they have a lot going on between today and Tuesday...positive 10-Q and the formal opening of the stem cell banking systems on the 15th
posted
August 11, 2006 Dallas, Texas, Aug 11, 2006 (M2 PRESSWIRE via COMTEX News Network) -- ********* Pre-Market Updates for Friday include Sure Trace Security Corporation (OTC: SSTY), CalbaTech Inc (OTCBB: CLBE), ProtoKinetix, Inc. (OTCBB: PKTX), Autoinfo Inc (OTCBB: AUTO), Earth Biofuels, Inc. (OTCBB: EBOF), and Composite Technology Corporation (OTCBB: CPTC) . ********* Pre-Market Updates feature companies with significant moves in either volume or price in the past two trading sessions. In our update we analyze recent news about the companies featured and detail the movement in the stock. If you would like to feature your publicly traded company in our alerts or on *********.com, email feature**********.com or call (469)252-3031.
CalbaTech Inc (OTCBB: CLBE) - Thursday's shares went up 1.67% to $0.061 with a total of 873,023 shares traded. On July 24, CalbaTech, Inc. announced that its wholly owned subsidiary, LifeStem, Inc. will begin operations of its Adult Stem Cell Microbank(TM) collection service on August 15th 2006. LifeStem's Stem Cell Microbank(TM) Service is the nation's first service to collect micro quantities of adult stem cells from multiple tissue sources. "We have completed the validation of our protocols to guarantee that our service will run smoothly at the time of launch," said James DeOlden, CEO. "LifeStem and its partners are now satisfied with the vitality and viability of the cells that have been collected." Additionally, CalbaTech, in coordination with LifeStem, announced that it will be offering a ten percent discount coupon for LifeStem's Stem Cell Microbank(TM) collection service, to shareholders of record as of August 10, 2006. The discount is available to the individual shareholder, or any member of the shareholder's immediate family at the shareholder's listed address.
CalbaTech, Inc., a life sciences company, provides products and platforms to the research market for biotech and pharmaceutical companies, as well as to academic institutions. Through its three divisions, Molecular Applications, Research Reagents, and Cellular Therapeutics, as well as wholly owned subsidiaries, including Molecula, Inc.; KD Medical, Inc.; LifeStem, Inc.; and MolecularWare, Inc., the company is developing products and technologies in biological discovery. The Molecular Applications division has an active program of molecular biology applications and research, including pathogen microarrays, diagnostics, electronic-based DNA detection systems, and DNA sample preparation. The Research Reagents division provides cell and molecular biology reagents and related consumables. It develops and sells research reagents for cell transfection, DNA and RNA purification, protein expression, gene expression analysis, and other fundamental products. The Cellular Therapeutics division focuses on cellular applications, particularly those relating to the use of adult stem cells. It includes cell-based research projects for the delivery of cell-based clinical therapies. CalbaTech was founded in 2002 and is based in Irvine, California.
posted
really impressed so far with the way its looking....low volume and holding up well.....like to see some block buys before close for the upcoming week!
posted
I jumped in yesterday. However I see that MSDN had afterhours new also, do you think this will have any effect on us?
Posts: 37 | From: Wyoming | Registered: Jul 2005
| IP: Logged |
quote:Originally posted by maxdog: I jumped in yesterday. However I see that MSDN had afterhours new also, do you think this will have any effect on us?
posted
now you can see that CLBE is not the only company interested in this market!! and we got a head start...LOL
Medistem's International Affiliate ICM Granted License to Operate Adult Stem Cell Bank and Clinic; Opening of Pioneering Facility Represents Threshold Event in Medistem's Business Plan to Deliver Stem Cell Therapies Business Wire - August 10, 2006 4:01 PM ET
Medistem Laboratories, Inc. (OTCBB:MDSM)(FWB:S2U), committed to the ethical development of next-generation medical therapies from non-controversial adult stem cell sources, has announced that its affiliate, the Institute for Cellular Medicine (ICM), has received approval from the Costa Rican Health Ministry to begin operations of its adult stem cell bank and clinic.
With the state-of-the-art stem cell bank and clinic now open, ICM will begin working hand-in-hand with medical doctors in the treatment of patients with stem-cell therapies based on Medistem's proprietary technologies. The ICM lab will apply Medistem's proprietary adult stem cell technologies that can be sourced from umbilical cords, placentas, fat, bone marrow, and muscle.
The opening of the ICM bank and clinic represents a critical milestone in Medistem's primary business plan to develop and deliver pioneering stem cell treatments on a fee-for-service basis through its international affiliates at facilities worldwide. Under its strategic business plan, Medistem with its affiliates plans to create potentially valuable intellectual property in the field of stem cell medicine.
The ICM laboratory will be one of the first stem cell banks in Latin America to produce the adult stem cells necessary for the development of stem cell based medical treatments. "We are very excited to be able to use Medistem's stem cell technology to produce stem cells for use by the medical community," said Dr. Fabio Solano, Medical Director of ICM. "We believe their technology holds a great deal of promise in the creation of important therapeutic solutions for seriously debilitating diseases."
The stem cell bank and clinic will work with the medical community in the treatment of patients with stroke, cerebral palsy and other neurological disorders. ICM also intends to develop treatments for a range of other health care needs, including cardiovascular disease.
Under a licensing agreement with ICM, which is controlled by Medistem's Chief Executive Officer, Medistem granted a license to ICM to use certain of its intellectual property and agreed to fund all necessary operating expenses in exchange for certain revenues and gross profits involving both adult stem cells and non-stem cell based activities.
posted
It isn't doing much today, I anticipated it moving more on the new. But, as you said nothing is moving much.
Posts: 37 | From: Wyoming | Registered: Jul 2005
| IP: Logged |
posted
don't be surprise to get a weekend PR on CLBE concerning Monday and Tuesday. A e-mail from IR just confirmed that another spa is right now in negotiation with Calbatech concerning stem cell therapy
posted
EOD action kicking in!!!! financials either after hours or Monday imo!!! banks opening Tuesday and are now in negotiations with another Spa company to!!
Stem cell breakthrough in Japan KYOTO, Japan, Aug. 11 (UPI) -- Japanese researchers have been able to make adult cells act like embryonic stem cells, at least in mice.
Shinya Yamanaka of Kyoto University said he believes the technique could end the debate on the destruction of embryos to obtain embryonic stem cells, the Milwaukee Journal Sentinel reported. If it is as successful with human cells as it is with mice, early embryos or blastocytes would no longer be needed.
Yamanaka and his colleague Kazutoshi Takahashi found 24 genes that are expressed in early embryos. They found that a combination of four of these cells could make adult cells "pluripotent."
In other words, they became like embryonic stem cells and capable of differentiating into many kinds of cells.
In addition to bypassing the ethical dilemmas of embryonic stem cell research, the technique could solve the problem of rejection by allowing a patient's own cells to be used for treatment.
But Robert Lanza of Advanced Cell Technology, a Massachusetts biogenetics company, warned there are potential pitfalls. He told the Journal Sentinel one of the genes involved is associated with cancer and the genetic manipulation also makes cells more prone to become cancerous.
posted
here is whats in the works for this week...
the stem cell banking system formally opens tomorrow on the 15th. we recieved info Friday that Calbatech is also in final negotiations with another Medspa company. The first Medspa company Solena will be opening 38 to 50 locations before year end and have already opened many so far. CLBE substantially owns a good portion of Solena and they are far more then just partners in this. CLBE will be profitable in 2006 per the CEO.....we expect the financials anytime now more then likely sometime today. Health care providers such as Blue Cross/Blue Shield will eventually require stem cell banking to qualify for insurance imo,that way they remove a lot of risk of long term health care issues per individual.IMO CLBE should be at or near .50'ish by year end but could go higher. I can see this hitting $2 to $4 within the next 12 to 18 months.The banking/theropy system is a double digit billion dollar market and growing and thats just one division of Calbatech.
posted
Looks like today will be a good day. Not even 10 minutes into the day and volume is well above normal.
-------------------- Before you criticize someone, try walking a mile in their shoes, then when you do, you'll be a mile away and have their shoes. Posts: 1450 | From: TX | Registered: Feb 2006
| IP: Logged |
posted
I feel now that CalbaTech has the base set up and the ducks are all in a row (all the sub-divisions) that compliment each other....with the banking system opening tomorrow and other Spa's contacting CLBE this could get explosive.
posted
look at the buying increase at .065,I thru a tester out for 2825 shares and it took a while and in two partials....that tells me that buying blocks now is going to be very hard and even herder towards the end of the day imo.
It's a small world. KD Medical buys petri dishes from FRANCE (Plastiques Gosselin, John Gosselin in green shirt) buys ploycarbonate 1L bottles from TAIWAN (TriForest Industries, Steve Lin in white shirt) and develops new products with Dr. Syed Rehan of PAKISTAN (in burgandy shirt). Dinner was hosted by KD Medical's John Powers (gray shirt) in Las Vegas, NV, original home of our parent, public company Calbatech (now in San Diego, CA)
posted
as some on the other board stated.....since the Medspa's are a big thing for many and since Hollywood is one of the locations it would surely be nice to see some Celeb's getting this done!!!
posted
for the hell of it I e-mailed paul and also called the company concerning the celeb's angle...heres what I sent and also left the same message on CalbaTechs line at 949-450-9910....LOL...that would be great publicity and maybe a few of you would like to call them and give some opinions.
Paul
You may think this is going out on a limb but have you or the company considered contacting the Governor of CA (Arnold)? Since he is pro stem cell research do you think he would consider getting the banking done? Hell give it to him free of charge because the publicity would be phenomenal!! maybe even some other celebs to!
-------------------- Before you criticize someone, try walking a mile in their shoes, then when you do, you'll be a mile away and have their shoes. Posts: 1450 | From: TX | Registered: Feb 2006
| IP: Logged |
posted
can you imagine how this would hit the fan if they announce that Arnold will be at their Med Spas for his first stem cell extraction!!! this stock would hit the dollars quick!!
posted
I just e-mailed the Gov!! also sent him the last PR by CLBE concerning the opening of the stem cell banking system and ask if he would consider it since he is a health advocate and supports stem cell technology!
CalbaTech, Inc. (OTC Bulletin Board: CLBE), an emerging life sciences company (http://www.CalbaTech.com) concentrating on banking adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech, pharmaceutical research market and to academic institutions, announced today that its wholly owned subsidiary, LifeStem, Inc. will begin operations of its Adult Stem Cell Microbank(TM) collection service on August 15th 2006.
LifeStem's Stem Cell Microbank(TM) Service is the nation's first service to collect micro quantities of adult stem cells from multiple tissue sources. "We have completed the validation of our protocols to guarantee that our service will run smoothly at the time of launch," said James DeOlden, CEO. "LifeStem and its partners are now satisfied with the vitality and viability of the cells that have been collected."
A number of individuals have already expressed interest in being the first to store their stem cells with LifeStem once the Service has begun. The company will begin enrolling clients immediately. LifeStem will also begin its marketing efforts immediately to take advantage of the time between today's date and the 15th of August to schedule other individual's stem cell harvests.
Additionally, CalbaTech, in coordination with LifeStem, announced that it will be offering a ten percent discount coupon for LifeStem's Stem Cell Microbank(TM) collection service, to shareholders of record as of August 10, 2006. The discount is available to the individual shareholder, or any member of the shareholder's immediate family at the shareholder's listed address.
CalbaTech's wholly owned subsidiary LifeStem has developed a unique process to harvest stem cells from two tissue sources, in micro quantities, to be cryopreserved for possible future therapeutic use. The collection of stem cells from two different tissue sources increases the potential for possible treatment options of more diseases.
About CalbaTech
CalbaTech, Inc. (OTC Bulletin Board: CLBE) is an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions.
Contact: Paul Knopick E&E Communications (949) 707-5365 pknopick*eandecommunications.com